Literature DB >> 22105236

Predicting response to growth hormone treatment.

Leena Patel1, Peter E Clayton.   

Abstract

Despite extensive experience over the past 25 y in managing growth failure with growth hormone (rhGH), predicting treatment efficacy in individual children remains a challenge. In this paper, the authors present the methods that are currently available to clinicians for predicting the growth response, and other more sophisticated techniques which have the potential to pave the way for individualised therapy in the future.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22105236     DOI： 10.1007/s12098-011-0611-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  59 in total

Review 1.  Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

Authors:  Anders Juul
Journal:  Growth Horm IGF Res       Date:  2003-08       Impact factor: 2.372

2.  The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.

Authors:  G Binder; F Baur; R Schweizer; M B Ranke
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

3.  Noonan syndrome: relationships between genotype, growth, and growth factors.

Authors:  Jean-Marie Limal; Béatrice Parfait; Sylvie Cabrol; Damien Bonnet; Bruno Leheup; Stanislas Lyonnet; Michel Vidaud; Yves Le Bouc
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

Review 4.  Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review.

Authors:  Annalisa Deodati; Stefano Cianfarani
Journal:  BMJ       Date:  2011-03-11

5.  Final height after long-term growth hormone treatment in Turner syndrome. European Study Group.

Authors:  J Van den Broeck; G G Massa; A Attanasio; A Matranga; J L Chaussain; D A Price; D Aarskog; J M Wit
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

Review 6.  Predicting growth in response to growth hormone treatment.

Authors:  Michael B Ranke; Anders Lindberg
Journal:  Growth Horm IGF Res       Date:  2008-09-27       Impact factor: 2.372

7.  Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.

Authors:  Lei Wan; Wei-Cheng Chen; Yuhsin Tsai; Yu-Tsun Kao; Yao-Yuan Hsieh; Cheng-Chun Lee; Chang-Hai Tsai; Chih-Ping Chen; Fuu Jen Tsai
Journal:  Pediatr Res       Date:  2007-12       Impact factor: 3.756

8.  The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy.

Authors:  L Fernández-Pérez; J Nóvoa; N Ståhlberg; R Santana-Farré; M Boronat; D Marrero; L Henríquez-Hernández; G Norstedt; A Flores-Morales
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10-22       Impact factor: 3.478

9.  Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.

Authors:  Björn Andersson; Gunnel Hellgren; Andreas F M Nierop; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2009-11-02       Impact factor: 2.480

10.  A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature.

Authors:  Gunnel Hellgren; Björn Andersson; Andreas Fm Nierop; Jovanna Dahlgren; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2008-12-11       Impact factor: 2.480
View more
  4 in total

1.  Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?

Authors:  Saartje Straetemans; Jean De Schepper; Muriel Thomas; Sylvie Tenoutasse; Véronique Beauloye; Raoul Rooman
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-26       Impact factor: 5.555

2.  Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.

Authors:  Ju Young Yoon; Chong Kun Cheon; Jung Hyun Lee; Min Jung Kwak; Hyun-Ji Kim; Ye Jin Kim; Jeong Eun Lee; Woo Yeong Chung; Jeongyun Kim; Jae-Ho Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-01-17

3.  Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children.

Authors:  Dandan Xu; Chengjun Sun; Zeyi Zhou; Bingbing Wu; Lin Yang; Zhuo Chang; Miaoying Zhang; Li Xi; Ruoqian Cheng; Jinwen Ni; Feihong Luo
Journal:  BMC Med Genet       Date:  2018-05-16       Impact factor: 2.103

4.  Poor growth response during the first year of growth hormone treatment in short prepubertal children with growth hormone deficiency and born small for gestational age: a comparison of different criteria.

Authors:  Raoul Rooman; Jean De Schepper; Saartje Straetemans; Muriel Thomas; Margarita Craen
Journal:  Int J Pediatr Endocrinol       Date:  2018-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.